Signal Relief Patch in Musculoskeletal Pain
Completed · Not applicable
Conditions studied: Musculoskeletal Pain
In brief
assess the efficacy of the Signal Relief patch for the management of general musculoskeletal pain
Key facts
- Study ID
- NCT05288114
- Run by
- Signal Relief
- People needed
- 44
- Starts
- 2022-01-21
- Expected to finish
- 2022-09-29
- Last updated by the study team
- 2022-10-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or female subject aged ≥ 18 years.
- Currently seeking treatment for chronic musculoskeletal pain management.
- Visual analog scale score > 4 at baseline.
- Willing to refrain from the use of prescription pain medications during study participation.
- Able and willing to provide informed consent.
You may not qualify if…
- 1. Receiving other investigational agents or on another clinical trial. 2. In emergent need for pain management. 3. Acute injury requiring rapid intervention or treatment. 4. The subject is using prescription medications (e.g., celecoxib, codeine, oxycodone, prednisone, etc.) for pain management regularly or PRN.
- The subject is currently undergoing or planning to begin physical therapy. 6. The subject is planning to begin a new exercise routine. 7. Subject has implantable pain device, pacemaker, defibrillator, or other neuromodulation implantable device 8. Known to be pregnant.
Where it is running
- Valley of the Sun Institute for Pain Management — Scottsdale, Arizona, United States
- Helios Health — Sedona, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.